Please elaborate on the injunction risk that caused BMJ to decide it did not need to contact or get comment from those it accused of mis-, mal- and non-feasance. Recent injunctions in the UK have been filed to protect privacy and national security. Does your narrative articulate a new threat of prior restraint? Based on what case of prior restraint, exactly?